Back to Search
JESSICA WROBEL, M.D.
M.D.
Anesthesiology Physician
NPI: 1255770566Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
256329(MA)
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
270414(MA)
Research & Publications (20)
Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.
PMID 18973288·J Med Chem·2008
7-preclinical
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole template.
PMID 19251413·Bioorg Med Chem Lett·2009
7-preclinical
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.
PMID 19318684·J Lipid Res·2009
7-preclinical
Biarylether amide quinolines as liver X receptor agonists.
PMID 19162487·Bioorg Med Chem·2009
7-preclinical
Clinical factors associated with a conservative gait pattern in older male veterans with diabetes.
PMID 19389247·J Foot Ankle Res·2009
8-other
Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta.
PMID 19394832·Bioorg Med Chem·2009
7-preclinical
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R).
PMID 19271735·J Med Chem·2009
7-preclinical
Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR).
PMID 19159286·J Med Chem·2009
7-preclinical
7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists.
PMID 18504132·Bioorg Med Chem·2008
7-preclinical
2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor.
PMID 18511284·Bioorg Med Chem·2008
7-preclinical
Carboxylic acid based quinolines as liver X receptor modulators that have LXRbeta receptor binding selectivity.
PMID 18023179·Bioorg Med Chem Lett·2008
7-preclinical
The syndrome of inappropriate anti-diuretic hormone secretion concurrent with an acute exacerbation of cystic fibrosis.
PMID 18707924·J Cyst Fibros·2008
5-case
Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348).
PMID 18318463·J Med Chem·2008
7-preclinical
Differing pharmacological activities of thiazolidinone analogs at the FSH receptor.
PMID 18252197·Biochem Biophys Res Commun·2008
7-preclinical
Use of chlorhexidine-impregnated patch at pin site to reduce local morbidity: the ChIPPS Pilot Trial.
PMID 18205786·Int Wound J·2008
8-other
1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators.
PMID 18722119·Bioorg Med Chem Lett·2008
8-other
Guest Editorial: are diabetes-related wounds and amputations worse than cancer?
PMID 18154621·Int Wound J·2007
4-observational
In vitro and in vivo characterization of a novel nonsteroidal, species-specific progesterone receptor modulator, PRA-910.
PMID 18540573·Ernst Schering Found Symp Proc·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 75 FRANCIS ST
BOSTON, MA 02115 - Phone
- (617) 732-8210
Quick Facts
- NPI
- 1255770566
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile